Submitted by Anonymous (not verified) on 4 December 2023 - 16:15
Human medicines European public assessment report (EPAR): Yesafili, aflibercept, Macular Edema;Retinal Vein Occlusion;Diabetic Retinopathy;Myopia, Degenerative;Diabetes Complications, Date of authorisation: 15/09/2023, Revision: 1, Status: Authorised
Source: